Time resolved absorption study of the reaction of hydroxyurea with sickle cell hemoglobin
- PMID: 9545536
- DOI: 10.1016/s0304-4165(97)00132-3
Time resolved absorption study of the reaction of hydroxyurea with sickle cell hemoglobin
Abstract
Hydroxyurea has been mixed with hemoglobin S and the reaction was studied using electronic absorption spectroscopy as a function of time and wavelength. The rate of conversion of oxyhemoglobin S to other species was determined and the nature of the reaction products was studied. We also report the formation of methemoglobin (and other reaction products) when deoxyhemoglobin S is combined with hydroxyurea. The probable increase in the formation of methemoglobin, and other potential reaction products such as nitric oxide-hemoglobin, in patients with sickle cell anemia who are taking hydroxyurea as a therapeutic drug is discussed in terms of the pathophysiology of the disease. It is proposed that methemoglobin and possibly nitric oxide-hemoglobin formation may partially explain beneficial effects observed in these patients before their levels of fetal hemoglobin have increased.
Similar articles
-
The reaction of deoxy-sickle cell hemoglobin with hydroxyurea.Biochim Biophys Acta. 1999 Aug 5;1428(2-3):381-7. doi: 10.1016/s0304-4165(99)00071-9. Biochim Biophys Acta. 1999. PMID: 10434057
-
In vitro exposure to hydroxyurea reduces sickle red blood cell deformability.Am J Hematol. 2001 Jul;67(3):151-6. doi: 10.1002/ajh.1098. Am J Hematol. 2001. PMID: 11391710
-
Iron nitrosyl hemoglobin formation from the reactions of hemoglobin and hydroxyurea.Biochemistry. 2002 Feb 19;41(7):2466-74. doi: 10.1021/bi011470o. Biochemistry. 2002. PMID: 11841242
-
Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors.Expert Rev Hematol. 2012 Jun;5(3):303-11. doi: 10.1586/ehm.12.20. Expert Rev Hematol. 2012. PMID: 22780210 Review.
-
Targeting sickle cell disease root-cause pathophysiology with small molecules.Haematologica. 2019 Sep;104(9):1720-1730. doi: 10.3324/haematol.2018.207530. Epub 2019 Aug 8. Haematologica. 2019. PMID: 31399526 Free PMC article. Review.
Cited by
-
The role of beta93 Cys in the inhibition of Hb S fiber formation.Biophys Chem. 2007 May;127(3):181-93. doi: 10.1016/j.bpc.2007.02.002. Epub 2007 Feb 16. Biophys Chem. 2007. PMID: 17350155 Free PMC article.
-
Generation of nitroxyl by heme protein-mediated peroxidation of hydroxylamine but not N-hydroxy-L-arginine.Free Radic Biol Med. 2008 Sep 1;45(5):578-84. doi: 10.1016/j.freeradbiomed.2008.04.036. Epub 2008 May 3. Free Radic Biol Med. 2008. PMID: 18503778 Free PMC article.
-
Hydroxyurea therapy mobilises arachidonic Acid from inner cell membrane aminophospholipids in patients with homozygous sickle cell disease.J Lipids. 2011;2011:718014. doi: 10.1155/2011/718014. Epub 2011 Sep 15. J Lipids. 2011. PMID: 21941660 Free PMC article.
-
Tracking Equilibrium and Nonequilibrium Shifts in Data with TREND.Biophys J. 2017 Jan 24;112(2):224-233. doi: 10.1016/j.bpj.2016.12.018. Biophys J. 2017. PMID: 28122211 Free PMC article.
-
Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase.J Clin Invest. 2003 Jan;111(2):231-9. doi: 10.1172/JCI16672. J Clin Invest. 2003. PMID: 12531879 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources